These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21310057)

  • 21. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
    ; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
    Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi].
    Ndayiragije A; Niyungeko D; Karenzo J; Niyungeko E; Barutwanayo M; Ciza A; Bosman A; Moyou-Somo R; Nahimana A; Nyarushatsi JP; Barihuta T; Mizero L; Ndaruhutse J; Delacollette C; Ringwald P; Kamana J
    Trop Med Int Health; 2004 Jun; 9(6):673-9. PubMed ID: 15189457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
    Alba S; Hetzel MW; Goodman C; Dillip A; Liana J; Mshinda H; Lengeler C
    Malar J; 2010 Jun; 9():164. PubMed ID: 20550654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
    Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
    BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.
    Talisuna AO; Daumerie PG; Balyeku A; Egan T; Piot B; Coghlan R; Lugand M; Bwire G; Rwakimari JB; Ndyomugyenyi R; Kato F; Byangire M; Kagwa P; Sebisubi F; Nahamya D; Bonabana A; Mpanga-Mukasa S; Buyungo P; Lukwago J; Batte A; Nakanwagi G; Tibenderana J; Nayer K; Reddy K; Dokwal N; Rugumambaju S; Kidde S; Banerji J; Jagoe G
    Malar J; 2012 Oct; 11():356. PubMed ID: 23107021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT).
    Ringsted FM; Massawe IS; Lemnge MM; Bygbjerg IC
    Malar J; 2011 Aug; 10():238. PubMed ID: 21843328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.
    Nsimba B; Guiyedi V; Mabika-Mamfoumbi M; Mourou-Mbina JR; Ngoungou E; Bouyou-Akotet M; Loembet R; Durand R; Le Bras J; Kombila M
    Malar J; 2008 Feb; 7():31. PubMed ID: 18267042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
    Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
    BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon.
    Sayang C; Gausseres M; Vernazza-Licht N; Malvy D; Bley D; Millet P
    Malar J; 2009 Jul; 8():174. PubMed ID: 19640283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors determining anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya.
    Watsierah CA; Jura WG; Oyugi H; Abong'o B; Ouma C
    Malar J; 2010 Oct; 9():295. PubMed ID: 20977741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ACTwatch project: methods to describe anti-malarial markets in seven countries.
    Shewchuk T; O'Connell KA; Goodman C; Hanson K; Chapman S; Chavasse D
    Malar J; 2011 Oct; 10():325. PubMed ID: 22039780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.
    Jiang M; Yang S; Yan K; Liu J; Zhao J; Fang Y
    PLoS One; 2013; 8(8):e70836. PubMed ID: 23936471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
    Quashie NB; Duah NO; Abuaku B; Koram KA
    Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).
    ; Phanalasy S
    Malar J; 2017 Apr; 16(1):169. PubMed ID: 28438155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
    Sado E; Sufa A
    BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.